A case of recurrent transverse myelitis and diplopia after meningomyeloradiculitis caused by Epstein-Barr virus

Clinical Neurology

Volumn 47, Issue 6, 2007, Pages 348-352

  Ochi, Masayuki ^a   Kawajiri, Masakazu ^a   Uetani, Eri ^a   Igase, Michiya ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diplopia; Epidural block; Epstein Barr virus; Multiple sclerosis; Transverse myelitis

Indexed keywords

ACICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; VIRUS CAPSID ANTIGEN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIPLOPIA; DRUG PULSE THERAPY; EPIDURAL ANESTHESIA; EPSTEIN BARR VIRUS; FEMALE; GAIT DISORDER; HUMAN; MENINGOMYELORADICULITIS; MULTIPLE SCLEROSIS; MYELITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RADICULITIS; SENSORY DYSFUNCTION; SEROLOGY; SPINAL CORD DISEASE; VIRUS INFECTION;

DIPLOPIA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; MENINGITIS; METHYLPREDNISOLONE; MIDDLE AGED; MYELITIS, TRANSVERSE; PULSE THERAPY, DRUG; RADICULOPATHY; RECURRENCE;

EID: 34547107591     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Japanese source
2. Japanese source
3. Merelli E, Bedin R, Sola P, et al: Encephalomyeloradiculopathy associated with Epstein-Barr virus: primary infection or reactivation? Acta Neurol Scand 1997; 96: 416-420
4. Corssmit EPM, Leverstein-van Hall MA, Portegies P, et al: Severe neurological complications in association with Epstein-Barr virus infection. J Neurovirol 1997; 3: 460-464
5. Ambler M, Stoll J, Tzamaloukas A, et al: Focal encephalomyelitis in infectious mononucleosis. A report with pathological description. Ann Intern Med 1971; 75: 579-583
6. Bray PF, Culp KW, McFarlin DE, et al: Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 1992; 42: 278-282
7. Shoji H, Kusuhara T, Honda Y, et al: Relapsing acute disseminated encephalomyelitis associated with chronic Epstein-Barr virus infection: MRI findings. Neuroradiology 1992; 34: 340-342
8. Majid A, Galetta SL, Sweeney CJ, et al: Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 2002; 125: 159-165
9. Martyn CN, Cruddas M, Compston DA: Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 167-168
10. Wandinger K-P, Jabs W, Siekhaus A, et al: Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55: 178-184
11. Cepok S, Zhou D, Srivastava R, et al: Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: 1352-1360
12. Höllsberg P, Kusk M, Bech E, et al: Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol Scand 2005; 112: 395-402
13. Buljevac D, van Doornum GJJ, Flach HZ, et al: Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1377-1381
14. Thacker EL, Mirzaei F, Ascherio A, et al: Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006; 59: 499-503
15. Wagner H-J, Munger KL, Ascherio A: Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur J Neurol 2004; 11: 833-834
16. Mühlau M, Bülow S, Stimmer H, et al: Seronegative Epstein-Barr virus myeloradiculitis in an immunocompetent 72-year-old woman. Neurology 2005; 65: 1329-1330
17. Zivadinov R, Nasuelli D, Tommasi MA, et al: Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 2006; 28: 262-269